Concepedia

Publication | Open Access

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

72

Citations

23

References

2010

Year

Abstract

EPO administration is a promising treatment for AMI.

References

YearCitations

Page 1